Immune-related gene risk score predicting the effect of immunotherapy and prognosis in bladder cancer patients

Background: Immune checkpoint inhibitor therapy has changed the treatment model of metastatic bladder cancer. However, only approximately 20% of patients benefit from this therapy, and robust biomarkers to predict the effect of immunotherapy are still lacking. In this study, we aimed to investigate...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Yuantao, Yuan, Gangjun, Tan, Xingliang, Luo, Sihao, Yang, Cong, Tang, Yi, Wang, Yanjun, Yao, Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577248/
https://www.ncbi.nlm.nih.gov/pubmed/36267410
http://dx.doi.org/10.3389/fgene.2022.1011390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577248/
https://www.ncbi.nlm.nih.gov/pubmed/36267410
http://dx.doi.org/10.3389/fgene.2022.1011390

Ejemplares similares